0.00Open0.02Pre Close0 Volume37 Open Interest100.00Strike Price0.00Turnover6630.85%IV28.07%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0069Delta0.0021Gamma3905.00Leverage Ratio-58.3651Theta0.0000Rho27.09Eff Leverage0.0000Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet